Some biomarkers that can be used as markers of AKI condition include interleukin-18 (IL-18)5, neutrophil-gelatinase-associated lipocalin (NGAL)6–8, and myeloperoxidase (MPO)9. This evidence concerns the gene IL18 and acute kidney injury.